Edition:
United States

Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

13.00SEK
11:29am EDT
Change (% chg)

0.10kr (+0.78%)
Prev Close
12.90kr
Open
13.00kr
Day's High
13.10kr
Day's Low
12.75kr
Volume
65,149
Avg. Vol
57,645
52-wk High
17.30kr
52-wk Low
7.50kr

ACTI.ST

Chart for ACTI.ST

About

Active Biotech AB is a Sweden-based company that focuses on pharmaceutical research and development in medical fields in which the immune system plays a central role. The Company’s research portfolio primarily includes projects for the development of drugs for the treatment of autoimmune and inflammatory diseases and cancer. As... (more)

Overall

Beta: 2.52
Market Cap(Mil.): kr1,159.82
Shares Outstanding(Mil.): 89.91
Dividend: --
Yield (%): --

Financials

  ACTI.ST Industry Sector
P/E (TTM): -- 41.55 39.69
EPS (TTM): -1.69 -- --
ROI: -32.04 -9.57 14.44
ROE: -59.16 -9.91 15.49

BRIEF-Active Biotech plans to develop tasquinimod for treatment of multiple myeloma

* Active biotech plans to develop tasquinimod for the treatment of multiple myeloma

Mar 23 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Sadif Analytics Prime
$25.00
Provider : Wright Reports
$75.00
Provider : Sadif Analytics Prime
$10.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.